We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Limited Access to Ultrasound Impedes Efforts to Help Prevent Pediatric Stroke

By HospiMedica International staff writers
Posted on 05 May 2009
The number of children with a specific blood disorder undergoing an ultrasound to help prevent stroke has increased significantly in the past 10 years since a major study demonstrated its benefits. More...
However, limited access to labs that perform this type of screening appears to be an obstacle to helping these children who are at a high risk of stroke.

In the study, published in the April 14, 2009, issue of the journal Neurology, the researchers tracked 157 children with sickle cell disease in northern California (USA) for an average of 8.5 years. Sickle cell disease is a lifelong blood disorder that increases a child's risk of stroke. Approximately 1 child out of 10 with the disease suffers a stroke by age 20.

For the study, researchers determined how many children underwent a transcranial Doppler ultrasound (TCD) screening since 1998, when a key study, known as the STOP (Stroke Prevention Trial in Sickle Cell Anemia) trial, was published. The STOP trial revealed a more than 90% reduction in the stroke rate of children with sickle cell disease who received a TCD screening and were identified as having a high risk of stroke and could therefore have blood transfusion therapy.

Since the STOP trial, the current study found the rate of TCD screening among children with sickle cell disease has increased six-fold while the yearly stroke rate has decreased by more than half. However, researchers found children living farther away from a vascular laboratory were less likely to be screened. "Stroke in children with sickle cell disease should be a largely preventable disease, however, not all children at risk are getting screened," said Heather J. Fullerton, M.D., MAS, from the University of California, San Francisco (UCSF; USA). "Limited access to labs that perform TCD screening, even among kids with comprehensive health insurance, appears to be a barrier to helping these kids reduce their high risk of stroke. Increased availability of these screening labs may help prevent stroke in these high risk children."

Guidelines from the American Academy of Neurology (St. Paul, MN, USA) recommend TCD screening of children with sickle cell disease beginning at age two.

Related Links:

University of California, San Francisco




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.